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Tinospora crispa is a wild plant in Malaysia. Malay community used this plant 
traditionally for various therapeutic purposes. Despite many studies conducted on its 
antidiabetic and antipyretic effects, no study has been designed to address the question 
whether T.crispa could work as an antioxidant and lipid lowering agent. The aim of this 
experiment is to study the lipid lowering and antioxidant effects of T.crispa in rabbits 
fed with high cholesterol diet. 
 
The in vitro study was conducted to determine the total antioxidant activity of T.crispa 
aqueous extract. The scavenging activity of T.crispa measured using DPPH analysis 
was 85.95±0.52%. The antioxidant activity of T.crispa measured via TBA test and 
FRAP assay was 39.20±2.97% and 0.89+0.03mmol/L respectively. The types of 
flavonoids found in T.crispa were catechin, luteolin, morin and rutin.    
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Thirty male New Zealand White rabbits were randomly divided into six groups for the 
in vivo studies. The normal control (NC) group was fed 100g/rabbit/day normal rabbit 
chow. Positive control (PC) and Simvastatin control (SC) groups were fed high 
cholesterol diet (HCD) (0.5% cholesterol). The SC group was supplemented 5 
mg/kg/day of Simvastatin. The treatment groups (T150, T300 and T450) were fed with 
HCD and 150, 300 and 450 mg/kg/day of T.crispa extract respectively. The 
experimental period was designed for 10 weeks. Ear vein blood sampling were 
collected at week 0 (w0), week 5 (w5) and week 10 (w10) for plasma analysis. At the 
end of the experiment, the animals were sacrificed via exsanguinations, the aorta were 
excised and examined for histomorphometric analysis. 
 
Through plasma analysis, the activity of gamma glutamyl transferase (GGT), aspartate 
amino transferase (AST) and alanine amino transferase (ALT) were significantly lower 
(p<0.05) in group T450 at w10 compared to group PC. Group T150 and T300 had a 
significantly lower (p<0.05) total cholesterol (TC) level compared to PC at w10. Group 
T450 had a significantly higher (p<0.05) TC level against PC. All groups supplemented 
with T.crispa had a significantly higher (p<0.05) in high density lipoprotein (HDL) 
level and significantly lower (p<0.05) LDL level compared to PC at w10. The TG level 
of T150 and T450 were significantly decreased (p<0.05) from w5 to w10. Activity of 
catalase (CAT) in T150, T300 and T450 were significantly lower (p<0.05) at w10 
compared to PC. Group T450 had significantly higher (p<0.05) total antioxidant activity 
(TAA), glutathione peroxidase (GSH-Px) and superoxide dismutase (SOD) activities 
compared to PC at w10. No foam cell formation was visible in aorta of rabbits in group 
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NC, SC and T450. However, there were visible foam cell formation in the aorta of 
group PC, T150 and T300. 
In conclusion, this study suggested that supplementation of 450 mg/kg of T.crispa 
extract would be able to reduce or retard the progression of atherosclerotic plaque 
development induced by dietary cholesterol. The enhanced serum HDL, increase in 
antioxidant status and flavonoids composition may be the possible underlying 
mechanisms of antiatherogenic effect of T.crispa. 
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Tinospora crispa merupakan sejenis tumbuhan yang tumbuh meliar di Malaysia. 
Masyarakat Melayu menggunakan tumbuhan ini secara tradisional untuk pelbagai 
tujuan perubatan. Walaupun banyak kajian telah dijalankan untuk mengkaji kesannya 
sebagai antidiabetik dan antipiretik, tiada kajian terhadap kesannya sebagai antioksidan 
dan agen penurun lipid. Matlamat kajian ini dijalankan adalah untuk mengkaji kesan 
Tinospora crispa sebagai agen perendah lipid dan antioksidan pada arnab yang diberi 
diet tinggi kolesterol. 
 
Kajian in vitro telah dilakukan untuk menentukan aktiviti antioksidan ekstrak akuas 
T.crispa. Keputusan DPPH menunjukkan penghapusan radikal bebas oleh T.crispa ialah 
85.95±0.52%. Keputusan TBA dan FRAP masing-masing menunjukkan aktiviti 
antioksida T.crispa sebanyak 39.20±2.97% dan  0.89+0.03mmol/L. Catechin, luteolin, 
morin dan rutin merupakan jenis-jenis flavonoid yang dikenalpasti dalam T.crispa.    
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Untuk kajian in vivo,  tiga puluh arnab jantan baka New Zealand dengan berat badan 
purata 2.5-3.0 kg dibahagi secara rawak kepada 6 kumpulan. Kumpulan NC, PC dan SC 
adalah kumpulan kawalan negatif dan positif yang diberi makanan standard arnab; diet 
tinggi kolesterol (makanan standard arnab dicampurkan dengan 0.5% kolesterol; dan 
diet tinggi kolesterol (HCD) dengan 5mg/kg simvastatin masing-masing. Kumpulan 
T150, T300 dan T450 bertindak sebagai kumpulan rawatan melalui pemberian diet 
tinggi kolesterol (HCD) bersama suplemen 150, 300 dan 450mg/kg ekstrak T.crispa 
masing-masing. Jangkamasa kajian adalah selama 10 minggu. Darah dikumpul melalui 
vein telinga pada minggu 0 (m0), 5 (m5) dan 10 (m10) dan plasma digunakan untuk 
analisis biokimia. Aorta diasingkan untuk penelitian selanjutnya 
 
Aktiviti gamma glutamyl transferase (GGT), aspartate amino transferase (AST) dan 
alanine amino transferase (ALT) menunjukkan aras yang rendah secara signifikan 
(p<0.05) di dalam T450 pada m10 berbanding PC. Kumpulan T150 dan T300 
menunjukkan aras TC yang rendah secara signifikan (p<0.05) berbanding PC pada m10. 
Manakala, pada m10, T450 menunjukkan peningkatan aras TC secara signifikan 
(p<0.05) berbanding PC. Kesemua kumpulan yang diberi T.crispa menunjukkan 
peningkatan aras kolesterol lipoprotein ketumpatan tinggi (HDL) dan penurunan aras 
LDL secara signifikan (p<0.05) berbanding PC pada m10. Kadar TG di dalam 150CTC 
dan 450CTC menurun secara signifikan (p<0.05) dari m5 hingga m10 berbanding PC. 
Aktiviti katalase (CAT) di dalam T150, T300 dan T450 adalah rendah secara signifikan 
(p<0.05) pada m10 berbanding PC. Kumpulan T450 menunjukkan peningkatan aktiviti 
total antioksida (TAA), gluthatione peroxidase (GSH-Px) dan superoxide dismutase 
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(SOD) secara signifikan (p<0.05) berbanding PC pada m10. Tiada pembentukan sel 
busa kelihatan pada aorta arnab dalam NC, SC dan 450CTC, tetapi ia kelihatan pada 
aorta arnab yang diberi diet tinggi kolesterol dan pada dua kumpulan rawatan yang 
diberi suplemen 150 dan 300mg/kg T.crispa. 
 
Sebagai kesimpulan, kajian ini mencadangkan suplemen ekstrak T.crispa sebanyak 
450mg/kg mungkin boleh mengurangkan atau menghentikan pembentukan plak 
aterosklerosis terhasil dari makanan mengandungi tinggi kolesterol. Peningkatan HDL, 
status antioksida dan komposisi flavonoid mungkin merupakan penyumbang kepada 
kesan T.crispa sebagai anti-aterogenik. 
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CHAPTER 1 
INTRODUCTION 
Atherosclerosis is a chronic inflammatory disease (Ross, 1993) and the major cause of 
cardiovascular problems (James, 2004). It is characterised by the accumulation of lipid 
in the artery wall. The common risk factors for atherosclerosis are 
hypercholesterolemia, hypertension and cigarette smoking (James, 2004). The risk of 
atherosclerosis increases with excessive rise in the concentration of the important class 
of lipoproteins, known as low density lipoprotein (LDL) (Franco and Cinzia, 2003).  
Studies in hypercholesterolemic animal models indicate that oxidation of LDL is likely 
to play an important role in atherogenesis. High levels of cholesterol is one of the major 
risk factor for the development of cardiovascular diseases (CVD) including 
atherosclerosis, myocardial infarction, heart attacks and cerebral paralysis (Wald and 
Law, 1995).  Decreased of cholesterol level in blood, particularly the atherogenic 
lipoproteins (very low density lipoprotein, VLDL and LDL) and an increase in 
protective high density lipoprotein (HDL) fraction can be considered as beneficial for 
cardiovascular disease prevention (Catherine et al., 2004). At present, there is a great 
deal of interest in the clinical benefit associated with raising high density lipoprotein 
(HDL) levels. This is partly because HDL has been shown to be a strong, independent 
and inverse risk factor for coronary heart disease (CHD) (Yusuf et al., 2004). 
Free radicals are defined as any molecules or atoms with one or more unpaired 
electrons. With the possession of the unpaired electrons, free radicals are usually 
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